8-K
Current Report
Tempest Therapeutics, Inc. Filed Acc 0001193125-21-281694
Bylaws or fiscal year change
- Item 5.03 Amendments to articles or bylaws; change in fiscal year
From the SEC's structured data for this filing
Loading d222030d8k.htm…